dr. T.J.N. Hiltermann

No picture available
t.j.n.hiltermann umcg.nl


  1. Management of immune checkpoint inhibitor-induced polymyalgia rheumatica

    van der Geest, K. S. M., Sandovici, M., Rutgers, A., Hiltermann, T. J. N., Oosting, S. F., Slart, R. H. J. A. & Brouwer, E., 4-Sep-2020, In : Annals of the Rheumatic Diseases. 2 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  2. Adherence and Concordance between Serious Illness Care Planning Conversations and Oncology Clinician Documentation among Patients with Advanced Cancer

    Geerse, O. P., Lamas, D. J., Bernacki, R. E., Sanders, J. J., Paladino, J., Berendsen, A. J., Hiltermann, T. J. N., Lindvall, C., Fromme, E. K. & Block, S. D., 22-Jun-2020, In : Journal of Palliative Medicine. 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes

    Hurkmans, D. P., Tamminga, M., van Es, B., Peters, T., Karman, W., van Wijck, R. T. A., van der Spek, P. J., Tauber, T., Los, M., van Schetsen, A., Vu, T., Hiltermann, T. J. N., Schuuring, E., Aerts, J. G. J. V., Chen, S. & Groen, H. J. M., Aug-2020, In : Lung Cancer. 146, p. 341-349 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (96) »

  1. Treatment, pharmacological and non-pharmacological of lung cancer

    Jeroen Hiltermann (Invited speaker)

    Activity: Talk or presentationProfessional

  2. WCLC Toronto 2019

    Jeroen Hiltermann (Participant)

    Activity: Participating in or organising an eventParticipation in conferenceProfessional

View all (27) »

ID: 403191